Salcatonin
Generic medicine reference
Not yet clinically reviewed
This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.
Overview
Salcatonin is a synthetic polypeptide structurally similar to natural salmon calcitonin.
Indications
Salcatonin is primarily indicated in conditions like Osteolysis, Osteoporosis, Paget's disease, and can also be given in adjunctive therapy as an alternative drug of choice in Hypercalcemia.
Contraindications
Salcatonin is contraindicated in conditions like Hypocalcemia, Pregnancy, Lactation, Hypersensitivity to any component of product.
Side Effects
The symptomatic adverse reactions produced by Salcatonin are more or less tolerable and if they become severe, they can be treated symptomatically, these include Nausea, Vomiting, Tremors, Abdominal pain, Skin rashes, Flushing, Rhinitis, Tingling of the hand, Unpleasant taste.
Warnings
The possibility of a systemic allergic reaction should be borne in mind, and appropriate measures of treatment of a hypersensitivity reaction should be readily available. Skin testing should be considered prior to initiating salmon calcitonin therapy and the drug should not be given to patients with a positive skin test. The possibility of hypocalcemic tetany following salmon calcitonin administration should be considered, and calcium injection should be readily available, particularly during administration of the first several doses of salmon calcitonin.
High Risk Groups
Drug should not be given to Pregnant Mothers. If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
100 IU (100 (100)) 24 hourly SC/IM — For paget''s disease
4 IU/kg (4 (4)) 12 hourly SC/IM — For hypercalcemia: If the response to this dosage is not satisfactory after 1 to 2 days, dosage may be increased up to 8 IU/kg every 12 hours. If there is no satisfactory improvement after another 2 days, dosage may be increased to a maximum of 8 IU/kg every 6 hours.
Child Dosage
No child dosage information is recorded for this medicine yet.
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
No data regarding the interactions of Salcatonin was found.
Storage
Nasal spray, Inj
Available Brands in Pakistan
3 active brands listed alphabetically.
MIACALCIC
ActiveNOVARTIS PHARMA (PAK) LTD
DML: MIACALCIC
Nasal SprayInj
SALMOCAL
ActiveS.J. & G. FAZUL ELLAHIE (PVT) LTD.
DML: SALMOCAL
Inj
SALMOCAL NASAL
ActiveS.J. & G. FAZUL ELLAHIE (PVT) LTD.
DML: SALMOCAL NASAL
Spray
1 additional record is present but flagged "Unverified / Legacy" and not listed.
